Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human)
Clinical trial NCT03351933 · COMPLETED
Trial details
- NCT number
- NCT03351933
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-04-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.